1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Disease Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Disease Market, United Kingdom
3.1 Cardiac Disease Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Cardiac Marker Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Cardiac Marker Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
3.4 Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United Kingdom, Cardiac Disease Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Siemens Healthineers AG
4.3.1 Company Overview
4.4 Danaher Corp
4.4.1 Company Overview
4.5 Quidelortho Corp
4.5.1 Company Overview
4.6 bioMerieux SA
4.6.1 Company Overview
5 Cardiac Disease Market Pipeline Products6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 EDX Medical Group Raises USD0.38 Million in Private Placement of Shares
7 Recent Developments
7.1 Corporate Communications
7.1.1 Sep 30, 2024: EDX Medical Group: Annual General Meeting Results
7.2 Financial Announcements
7.2.1 Sep 04, 2024: EDX Medical Group Releases Annual Report and Financial Statements for the Period Ending March 31, 2024
7.3 Other Significant Developments
7.3.1 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
7.4 Strategy And Business Planning
7.4.1 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Table 4: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Table 5: Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
Table 6: Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 7: Cardiac Disease Market Pipeline Products
Table 8: EDX Medical Group Raises USD0.38 Million in Private Placement of Shares
Table 9: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Figure 4: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Figure 5: Cardiac Disease Market, United Kingdom, Company Share (%), 2024